Safety and Surgical Performance Study of Aurosleek Surgical Blades (Aurosleek)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01763593|
Recruitment Status : Unknown
Verified April 2013 by Aurolab.
Recruitment status was: Recruiting
First Posted : January 9, 2013
Last Update Posted : April 30, 2013
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||35 participants|
|Official Title:||A Prospective, Open Label, Observational Study To Evaluate The Safety And Surgical Performance Of Surgical Blade (Aurosleek) In Cataract Patients|
|Study Start Date :||March 2013|
|Estimated Primary Completion Date :||May 2013|
|Estimated Study Completion Date :||June 2013|
Patients having cataract will undergo surgery by using Aurosleek blades
- Physioclinical Characters [ Time Frame: 30 days ]
Assessment of physio-clinical characteristics of surgical blade such as handling of the blade, sharpness and smoothness of blade.
Handling of the surgical blade will be assessed in grades of difficult to handle,easy to handle and very easy to handle intraoperatively. Sharpness and smoothness of the blade will be rated as poor or optimum while performing cataract surgery.
- Post operative complications [ Time Frame: 30 days ]
The frequency and occurrence of post operative complications such as rhexis tear, posterior capsular rupture, severe corneal edema, severe iritis and anterior vitrectomy.
Post operative complications occurrence due to surgical blade will be observed and graded as none or mild or moderate or severe at surgery and post operative 30 days.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01763593
|Contact: Karthikumar S, M.Pharm||04523096100 ext firstname.lastname@example.org|
|Aravind Eye Hospital||Recruiting|
|Madurai, Tamilnadu, India, 625020|
|Contact: Neeraj Kumar Agrawal, MS 04524356100 ext 181 email@example.com|
|Principal Investigator:||Neeraj Kumar Agrawal, MS||Medical Officer|